Clinical Trial: A Clinical Trial to Validate Molecular Targets of Vorinostat in Patients With Stage I-III Non-Small Cell Lung Cancer

A Clinical Trial to Validate Molecular Targets of Vorinostat in Patients With Stage I-III Non-Small Cell Lung Cancer

Sponsor and Collaborators
Dartmouth-Hitchcock Medical Center
Merck

Contact
Konstantin H. Dragnev, MD
(603) 650-6345
[email protected]

Brendan M. Slagle, BS
(603) 653-0590
[email protected]

Principal Investigator
Konstantin H. Dragnev, MD
Dartmouth-Hitchcock Medical Center

Clinical Trials.gov Identifier
NCT00735826